ADGRB3 and bipolar disorder: Brain-specific angiogenesis inhibitor-3 has also been reported as one of the clock modulator genes that are closely linked to the bipolar disorder spectrum and lithium response [86], suggesting that BAI3 could be a target for the treatment of psychiatric and neurological disorders.